APA (7th ed.) Citation

Arribas, A., Napoli, S., Cascione, L., Sartori, G., Gaudio, E., Tarantelli, C., . . . Bertoni, F. (2021). 842P Secreted factors determine resistance to idelalisib in splenic marginal zone lymphoma (MZL) models. Annals of Oncology, 32, S779. https://doi.org/10.1016/j.annonc.2021.08.135

Chicago Style (17th ed.) Citation

Arribas, A.J, et al. "842P Secreted Factors Determine Resistance to Idelalisib in Splenic Marginal Zone Lymphoma (MZL) Models." Annals of Oncology 32 (2021): S779. https://doi.org/10.1016/j.annonc.2021.08.135.

MLA (9th ed.) Citation

Arribas, A.J, et al. "842P Secreted Factors Determine Resistance to Idelalisib in Splenic Marginal Zone Lymphoma (MZL) Models." Annals of Oncology, vol. 32, 2021, p. S779, https://doi.org/10.1016/j.annonc.2021.08.135.